PharmaCCX
Boston, US · Founded 2017 · Delaware corporation · 2 known investors
CCX offers an enterprise platform for market access, contract management, and pricing aimed at global pharmaceutical companies and payers. The software lets users plan, model, and analyze contract scenarios and coordinate contract administration between pharma and payers.
Enterprise SoftwareHealthtechSaaS
Founders & leadership
AS
Armen SolakhyanExecutive
PR
Peter RiceExecutive
NS
Nathan SigworthNamed on SEC filing
Board
JB
Julia BernsteinBoard director
BS
Investors · 2
Reported raises · per SEC filings
Form D private placements$11.7M disclosed across 3 rounds · 2018–2023
▶$5.4MraisedJul 2023 · 24 investors · Other TechnologyRule 506(b)
▶$5.4MraisedJul 2023 · 24 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Peter RiceExecutive Officer
- Nathan SigworthExecutive Officer, Director
- Julia BernsteinDirector
- Rob KniazDirector
- Barath Shankar SubramanianDirector
- Offering amount
- $5.4M
- Amount sold
- $5.4M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedMar 2020 · 4 investors · Other TechnologyRule 506(b)
▶$3MraisedMar 2020 · 4 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Nathan SigworthExecutive Officer, Director
- Barath Shankar SubramanianDirector
- Armen SolakhyanExecutive Officer
- Peter RiceExecutive Officer
- Julia BernsteinDirector
- Offering amount
- $7M
- Amount sold
- $3M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$3.3MraisedNov 2018 · 16 investors · Other TechnologyRule 506(b)
▶$3.3MraisedNov 2018 · 16 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Nathan SigworthExecutive Officer, Director
- Julia BernsteinDirector
- Barath Shankar SubramanianDirector
- Armen SolakhyanExecutive Officer
- Peter RiceExecutive Officer
- Offering amount
- $4.1M
- Amount sold
- $3.3M
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does PharmaCCX do?
- CCX offers an enterprise platform for market access, contract management, and pricing aimed at global pharmaceutical companies and payers. The software lets users plan, model, and analyze contract scenarios and coordinate contract administration between pharma and payers.
- Who are PharmaCCX's investors?
- PharmaCCX's investors include Accel, Hoxton Ventures.
- How much funding has PharmaCCX raised?
- PharmaCCX has disclosed $11.7M raised across 3 rounds.
- Where is PharmaCCX headquartered?
- PharmaCCX is headquartered in Boston, US.